ReviewNeurology and therapy2023

No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].

Scott D Newsome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.